Study2019Open access

Fish Oil Derived Omega 3 Fatty Acids Suppress Adipose NLRP3 Inflammasome Signaling in Human Obesity

Lee KR, Midgette Y, Shah R

Journal of the Endocrine Society · 43 citations

Review labels

Mechanisms only

Neutral facts our review recorded about how this study was done. They describe method, never whether we like the result.

How it was studied

Design
Randomized controlled trial (classified by our AI screen)
Studied in
People, plus animal or lab work
Main outcome
Mechanisms only

Who paid for it

Funding
Independent funding
Government
National Institute of Diabetes and Digestive and Kidney Diseases
Government
National Center for Advancing Translational Sciences
Government
NIDDK NIH HHS
Government
NCATS NIH HHS
Grants
National Institute of Diabetes and Digestive and Kidney Diseases (P30 DK-019525); National Center for Advancing Translational Sciences (UL1-TR-001878); National Institute of Diabetes and Digestive and Kidney Diseases (K23 DK095913); National Institute of Diabetes and Digestive and Kidney Diseases (DK095913)

Based on 4 listed funder(s).

Publication

Published
2018-12-24 · J Endocr Soc · vol. 3 · issue 3 · pp. 504–515
Publisher
Endocrine Society
Cited
56 citations · more than 94% of similar papers · 3.7× the field average
Impact
Top 10% most cited in its field
References
60 works
Access
Open access (journal) · CC-BY-NC-ND
Research areas
Fatty Acid Research and Health · Adipokines, Inflammation, and Metabolic Diseases · Adipose Tissue and Metabolism
Keywords
Fish oil, Inflammasome, Adipose tissue, Obesity, Fish <Actinopterygii>, Omega, Chemistry, Endocrinology, Internal medicine, Biochemistry, Medicine, Biology, Fishery, Receptor, Physics

3 authors

From US

  • Kailey Roberts LeeChildren's Hospital of Philadelphia
  • Yasmeen A. MidgetteChildren's Hospital of Philadelphia
  • Rachana D. Shah · correspondingChildren's Hospital of Philadelphia

Abstract

Context

The NRLP3 inflammasome is a multiprotein danger-sensing complex that serves as a critical link between obesity-related adipose inflammation and insulin resistance and has been shown in animal models to be inhibited by fish oil-derived long chain omega-3 polyunsaturated fatty acids (n-3 PUFA).

Objective

We conducted a clinical trial and in vitro experiments to test our hypothesis that n-3 PUFA suppress NLRP3 inflammasome in human obesity through downregulation of inflammasome gene expression in adipocytes and macrophages.

Design

Placebo-controlled clinical trial and in vitro coculture experiments with primary human adipocytes (from biopsy specimens) and human THP-1 monocyte-derived macrophages treated with eicosapentaenoic acid (EPA) and/or docosahexaenoic acid (DHA) vs vehicle control.

Setting

General community, research laboratory.

Patients and other participants

Obese (body mass index ≥ 30 kg/m2), nondiabetic males and females age 18 to 50. N = 25.

Interventions

Clinical trial: Eight-week treatment with 4 g Lovaza (EPA and DHA) or placebo. Cells culture: EPA and/or DHA at 100 µg/mL or vehicle control in culture medium.

Main outcome measures

Adipose tissue or adipocyte/macrophage mRNA expression of IL-1β and IL-18 and circulating IL-18 levels.

Results

Treatment of obese human subjects with fish oil supplements reduced expression of adipose inflammatory genes including inflammasome-associated IL-18 and IL-1β and circulating IL-18 levels. Both EPA and DHA reduced inflammasome gene expression in obese human adipose and human adipocyte and macrophages.

Conclusions

N-3 PUFA reduce NLRP3 inflammasome in human adipose through downregulation of gene expression in adipocytes and monocytes/macrophages and has potential as nutritional therapeutic agent in prevention of obesity-related inflammation.

Abstract via Europe PMC. Copyright remains with the authors or publisher (CC BY-NC-ND).

Community trust

Loading…

How much do you trust this study's findings?

0 · not at all10 · completely

Comments

Sign in to rate, comment on or flag this study.Sign in

Something wrong here?

Flag this study if its information, labels or funding look wrong. An editor reviews every flag.

Sign in to rate, comment on or flag this study.Sign in

Educational information about published research. Not medical advice, and not a recommendation to start or stop anything.